JBJS Essential Surgical Techniques and JBJS Open Access Now in PubMed Central
The Editors of The Journal of Bone & Joint Surgery (JBJS) are pleased to announce that JBJS Essential Surgical Techniques (EST) and JBJS Open Access (OA) are now archived in PubMed Central (PMC), the national repository of free full-text biomedical literature, and discoverable on PubMed.
Launched in 2011 and edited by Edward Cheng, MD, JBJS Essential Surgical Techniques offers readers an expanding online library of thoroughly vetted orthopaedic procedures, including high-quality instructional videos. Peer reviewed and derived from top-quality published clinical studies, EST articles and videos deliver detailed, practical surgical guidance to all orthopaedists—from seasoned practitioners to those just starting out in practice.
Launched in 2016, JBJS Open Access gives authors an open-access option bolstered by the outstanding service and editorial excellence that JBJS has delivered for more than 125 years. At the same time, orthopaedic clinicians and researchers worldwide benefit from all-inclusive access to the best clinical and basic-science content about musculoskeletal health and injury care. JBJS OA is co-edited by Eng Lee, MD, FRCSC and Robin Richards, MD, FRCSC.
To learn more about JBJS Essential Surgical Techniques, click here.
To learn more about JBJS Open Access, click here.
Call for Submissions: JBJS What’s Important Articles
Over the last two years, JBJS has published more than 20 What’s Important articles, with topics ranging from unhappy patients to innovations in orthopaedic education. In these 1,000-word articles, clinicians tell a thoughtful and personal story about a high-impact lesson they learned at some juncture in life that altered their worldview, enhanced them personally, and positively affected the care that they provide as orthopaedic physicians.
Because they are personal in nature, “What’s Important” submissions are not subject to the usual stringent peer-review process. Instead, they are reviewed by the Editor-in-Chief, who corresponds with the author if revisions are necessary and makes the final decision regarding acceptance. The accepted manuscript is then forwarded to JBJS staff for copyediting and publication.
Authors of these articles have received many comments suggesting that readers value What’s Important articles in unique ways. If you would like JBJS to consider a “What’s Important” story for publication, please submit a manuscript via Editorial Manager. When asked to select an article type, please choose Orthopaedic Forum and include “What’s Important:” at the beginning of the title.
Impact of Clinical Practice Guidelines on Use of Injections for Knee OA
In a recent OrthoBuzz post, I commented on the apparent benefits to patients when Scottish hip-fracture guidelines were followed. Now, in a “closer-to-home” study in the May 16, 2018 issue of JBJS, Bedard et al. examine the effects of AAOS clinical practice guidelines (CPGs) on the use of injections for knee osteoarthritis (OA). The authors used an insurance database housing more than 1 million knee OA patients to evaluate the change in rates of corticosteroid and hyaluronic acid injections from 2007 to 2015. This date range includes the periods before and after the publication of the AAOS CPGs for knee arthritis (both the first edition, published in early 2009, and the second edition, published in late 2013).
The authors found that the rate of hyaluronic acid injections by orthopaedic surgeons decreased significantly after both publications of the guidelines and that the utilization of corticosteroid injections appears to have plateaued since the most recently published guidelines. Still, almost 40% of all of the patients in the cohort received a corticosteroid injection, with 13% having received a hyaluronic acid injection. In absolute numbers, those percentages represent more than half a million injections, despite the facts that the evidence supporting either injection for the treatment of knee OA is weak at best and that almost half of the patients receiving one of these injections ended up getting a total knee replacement within a year.
While the changes in practice revealed by Bedard et al. may seem relatively small, they are a step in the right direction toward value-based care. CPGs are easy to pick apart, but they are developed carefully and for a good reason—to provide us with evidence-based recommendations for excellent patient care. It is gratifying to see that such guidelines are having a positive impact in our field.
Chad A. Krueger, MD
JBJS Deputy Editor for Social Media
May 2018 Article Exchange with JOSPT
In 2015, JBJS launched an “article exchange” collaboration with the Journal of Orthopaedic & Sports Physical Therapy (JOSPT) to support multidisciplinary integration, continuity of care, and excellent patient outcomes in orthopaedics and sports medicine.
During the month of May 2018, JBJS and OrthoBuzz readers will have open access to the JOSPT article titled “Quality of Life in Symptomatic Individuals After Anterior Cruciate Ligament Reconstruction, With and Without Radiographic Knee Osteoarthritis.”
The authors conclude that diagnosing radiographic osteoarthritis in symptomatic individuals after ACL reconstruction may be valuable, because targeted strategies to facilitate participation in satisfying activities have the potential to improve quality of life in these patients.
More Progress in Preventing Secondary Fragility Fractures
How well do fracture liaison services (FLSs) work in terms of patients who’ve had a fragility fracture receiving a recommendation for anti-osteoporosis treatment? Very well, according to findings from an analysis of more than 32,000 patients by Dirschl and Rustom in the April 18, 2018 edition of The Journal of Bone & Joint Surgery.
A fracture liaison service is a coordinated, multidisciplinary model of care designed to reduce the risk of future fractures among patients who’ve sustained a primary fragility fracture. (Click here for another recent JBJS article about the FLS model.) The American Orthopaedic Association (AOA) has been a major proponent of the FLS model, and it is a cornerstone of the AOA’s “Own the Bone” national quality-improvement program.
Dirschl and Rustom found that between 2009 and 2016, at 147 sites participating in an FLS through Own the Bone, 72.8% of 32,671 patients initially evaluated for a fragility fracture received a recommendation for anti-osteoporosis treatment. That’s a vast improvement compared with previous reports that indicate only 20% of patients with a fragility fracture received either an osteoporosis evaluation or treatment. In this current study, a sedentary lifestyle and having a parent who had sustained a hip fracture were the patient factors associated with those most likely to receive a recommendation for treatment.
OrthoBuzz editors were surprised to read that anti-osteoporosis treatment was initiated in only 12.1% of the patients in this study. When we asked JBJS Editor-in-Chief Marc Swiontkowski, MD for a further explanation, he noted that the study captured data only from the initial post-fracture encounter between patients and FLS clinicians. The percentage of patients initiating treatment would have been much higher, he said, if the data had included those who followed up their initial FLS evaluation with a primary care physician. He also remarked that some people are dissuaded from taking an FDA-approved prescription anti-osteoporosis medication by the disproportionate focus on side effects that patients read in social media and the lay press. And there are some patients for whom prescription anti-osteoporosis drugs are truly contraindicated.
But with an estimated 2 million people in the US sustaining a fragility fracture each year, these results indicate substantial progress in practices that will prevent secondary fractures.
Click here for a listing of upcoming Own the Bone events.
Childhood Toe-Walking: Usually a Transient Condition
Parenting is a lot like medicine. Parents seek to “fix” their children, and physicians seek to “fix” their patients. However, sometimes the best “fix” is to observe closely, do nothing, and let nature take its course. That’s the main conclusion of the study by Engstrom et al. in the April 18, 2018 edition of JBJS. The authors set out to document the natural history of idiopathic toe-walking to determine how often the condition resolves without intervention.
After analyzing a cohort of more than 1,400 children, the authors found that 63 (5%) had been toe-walkers at some point as a toddler—but that almost 80% of those children spontaneously ceased being toe-walkers by the time they were 10 years of age. However, the authors found that children with ankle contractures before age 5 were unlikely to spontaneously cease toe-walking and would benefit from early surgical intervention. This study also demonstrated a correlation between neurodevelopmental comorbidities and toe-walking. Although 4 of the 8 children who still toe-walked at 10 years of age had received a neurodevelopmental diagnosis between the ages of 5.5 and 10 years, the authors state that “even in this subgroup of children, the idiopathic toe-walking seems, for the majority of children, to be a transient condition.”
Taken as a whole, this Level-I prognostic study provides relatively clear treatment pathways for clinicians and parents to follow when a child presents with toe-walking. The findings can be used to help calm the fears of parents regarding their child’s development while also giving surgeons the confidence to treat the majority of these children with observation unless there is a contracture of the calf musculature.
Chad A. Krueger, MD
JBJS Deputy Editor for Social Media
Fifth Anniversary of Boston Marathon Bombing
On the eve of the 2018 Boston Marathon, we wish all the participants a safe run tomorrow. And we remember all those who are still experiencing the aftermath of the 2013 Marathon Bombing.
Not a single person who reached a Boston hospital alive on April 15, 2013 died, a stunning result of years of preparation and teamwork. It Takes a Team provides a behind-the-scenes look at how the level 1 trauma centers involved that day ensured that their staffs had the emotional backing, resources, and systems in place so they could focus on their seriously injured patients. Click here to download the report for free.
We thank the many people whose dedication to disaster-preparedness helps ensure that the 2018 and future Boston Marathons will go on.
Outcomes from Shoulder Fusion Are Durable, Not Spectacular
Glenohumeral arthrodesis is a salvage operation, so most patients and surgeons considering this option don’t have expectations of spectacular functional outcomes. Improving stability and relieving pain are usually the main goals. In the April 4, 2018 edition of The Journal of Bone & Joint Surgery, a retrospective study by Wagner et al. sheds light on long-term results of this procedure (mean follow-up of 12 years) and the patient and surgical factors that might improve or worsen outcomes.
The authors reviewed electronic and paper medical records of 29 cases of glenohumeral arthrodesis performed between 1992 and 2009. They also analyzed patient questionnaires, which included DASH, SSV, and SF-36 scoring instruments.
All patients reported improvement in pain at the time of their latest postoperative follow-up. However, 12 patients (41%) had postoperative complications, including nonunions, fractures, and deep infections. Eleven patients (38%) required additional post-arthrodesis surgical procedures. The mean postoperative shoulder position was 60° in flexion and 13° in external rotation.
The authors identified the following correlations between patient/surgical factors and outcomes:
- Patients with a history of brachial plexus injuries had worse clinical and functional outcomes.
- Patients with shoulders fused in abduction and flexion of >25° had better shoulder function but a slightly higher risk of peri-fixation fracture.
- There were no significant outcome differences between procedures that used plate-and-screw and screw-only fixation. However, incorporation of the acromion in fixation was strongly associated with a lower risk of nonunion.
The authors conclude that despite the limitations of this complex salvage procedure, “its ability to relieve pain and to maintain reasonable upper-extremity function in select patients should not be overlooked.”
Does Residency Prepare Surgeons for Early Orthopaedic Practice?
One goal of an orthopaedic surgery residency is to prepare residents for the procedures they will perform when they are attendings. Yet, until the retrospective cohort study by Kohring et al. in the April 4, 2018 issue of The Journal, it remained unclear how similar a resident’s surgical case mix was compared to the cases attendings saw in early practice. Kohring et al. used data from both the Accreditation Council for Graduate Medical Education (ACGME) and the American Board of Orthopaedic Surgery (ABOS) to compare the types of procedures residents performed between 2010 and 2012 to the cases junior attendings submitted for the ABOS Part II examination between 2013 and 2015. The authors then categorized the cases by CPT codes and split them into adult and pediatric categories to allow for further comparison.
Here are a few interesting findings from the study:
- More than half of all adult and pediatric procedures performed during residency and by early-career attendings fell within the top 10 CPT code categories.
- Knee and shoulder arthroscopy were the most commonly performed cases in adults during both residency and early practice.
- Residents take part in total knee and total hip arthroplasties much more frequently than do attendings in early practice.
- Attendings in early practice treat more than twice the number of proximal femur fractures than do residents during residency.
- Residents are exposed to a much higher rate of spinal fusion cases than are seen by early-practice attendings.
Although the authors conclude that the “similarity between residency and early practice experience is generally strong,” this study highlights some of the disparities between the two cohorts, and these findings may inform further research aimed at improving training for orthopaedic surgeons. By themselves, however, these results should not be used to change the experience residents have during their training. The authors mention the limitations inherent when comparing these two cohorts, and I can testify that my clinical practice has evolved tremendously in the 3 years since I started as an attending.
Furthermore, with more than 90% of orthopaedic residents going on to complete a subspecialty fellowship immediately after residency, it is safe to say that the degree of similarity between residency and attending case experience will vary from surgeon to surgeon.
Chad A. Krueger, MD
JBJS Deputy Editor for Social Media
April 12 Webinar – Managing Osteoarthritis: Moving from Volume to Value
According to the CDC, in 2013, the total national arthritis-related medical care costs and earnings losses among adults were $303.5 billion, or 1% of the 2013 US Gross Domestic Product.
One response to statistics like that is the notion of “value-based health care.” How far has the orthopaedic community moved from a volume/fee-for-service-based model to one in which patients achieve the best possible musculoskeletal outcomes, payers expend the fewest possible dollars, and providers throughout the episodes of care are fairly compensated for their skill and compassion?
On Thursday, April 12, 2018 at 8:00 pm EDT, the American Orthopaedic Association (AOA) and The Journal of Bone & Joint Surgery (JBJS) will host a complimentary one-hour webinar that will answer these thorny questions by discussing the cost drivers behind the problem, where arthritis management stands currently, and where the value-based care bandwagon is heading.
Kevin Shea, MD, an expert in developing clinical practice guidelines, will discuss the crucial differences between “irrational variation” and “rational, patient-centered variation.”
Antonia Chen, MD, director of arthroplasty research at Harvard Medical School, will demystify the many attempts to measure and improve the quality of joint replacement and will address quality and value in the nonoperative management of osteoarthritis.
Gregory Brown, MD, a Tacoma, Washington-based surgeon specializing in knee reconstruction, will peer into the future of health insurance, patient empowerment, and robust orthopaedic registries.
Moderated by Douglas Lundy, MD, orthopaedic trauma surgeon at Resurgens Orthopaedics, this webinar will include a 15-minute live Q&A session during which attendees can ask questions of the panelists.
Recent Comments